-
21.Crystalline clopidogrel hydrobromide and processes for preparation thereof 审中-公开
标题翻译: 结晶氯吡格雷氢溴酸盐及其制备方法公开(公告)号:US20090187022A1
公开(公告)日:2009-07-23
申请号:US12221257
申请日:2008-07-31
申请人: Nina Finkelstein , Judith Aronhime , Limor Tessler
发明人: Nina Finkelstein , Judith Aronhime , Limor Tessler
IPC分类号: C07D471/02
CPC分类号: C07D495/04
摘要: Provided are crystalline forms of clopidogrel hydrobromide and processes for their preparation.
摘要翻译: 提供氯吡格雷氢溴酸盐的结晶形式及其制备方法。
-
公开(公告)号:US20080306268A1
公开(公告)日:2008-12-11
申请号:US12221350
申请日:2008-07-31
申请人: Nina Finkelstein , Judith Aronhime
发明人: Nina Finkelstein , Judith Aronhime
IPC分类号: C07D471/04
CPC分类号: C07D495/04
摘要: Provided are crystalline forms of clopidogrel hydrobromide and processes for their preparation.
-
23.Crystalline clopidogrel hydrobromide and processes for preparation thereof 审中-公开
标题翻译: 结晶氯吡格雷氢溴酸盐及其制备方法公开(公告)号:US20080300409A1
公开(公告)日:2008-12-04
申请号:US12221349
申请日:2008-07-31
申请人: Nina Finkelstein , Judith Aronhime
发明人: Nina Finkelstein , Judith Aronhime
IPC分类号: C07D471/02
CPC分类号: C07D495/04
摘要: Provided are crystalline forms of clopidogrel hydrobromide and processes for their preparation.
摘要翻译: 提供氯吡格雷氢溴酸盐的结晶形式及其制备方法。
-
24.Crystalline forms of pemetrexed diacid and processes for the preparation thereof 有权
标题翻译: 培美曲塞二酸的结晶形式及其制备方法公开(公告)号:US09156841B2
公开(公告)日:2015-10-13
申请号:US13070432
申请日:2011-03-23
申请人: Jonathan Busolli , Nicola Diulgheroff , Csilla Nemethne Racz , Moran Pirkes , Alessandro Pontiroli , Marco Villa , Judith Aronhime
发明人: Jonathan Busolli , Nicola Diulgheroff , Csilla Nemethne Racz , Moran Pirkes , Alessandro Pontiroli , Marco Villa , Judith Aronhime
IPC分类号: C07D487/04
CPC分类号: C07D487/04
摘要: Provided are crystalline forms of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid, pemetrexed diacid, and processes for the preparation thereof.
摘要翻译: 提供的是N- [4- [2-(2-氨基-4,7-二氢-4-氧代-1H-吡咯并[2,3-d]嘧啶-5-基)乙基]苯甲酰基] -L- 谷氨酸,培美曲塞二酸及其制备方法。
-
25.Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α 有权
标题翻译: 甲磺酸伊马替尼的多晶型形式和制备新型结晶形式以及无定型和形成α的方法公开(公告)号:US07977348B2
公开(公告)日:2011-07-12
申请号:US12148492
申请日:2008-04-17
申请人: Alexandr Jegorov , Miloslav Chudík , Judith Aronhime , Ale{hacek over (s)} Gavenda , Ji{hacek over (r)}í Faustmann
发明人: Alexandr Jegorov , Miloslav Chudík , Judith Aronhime , Ale{hacek over (s)} Gavenda , Ji{hacek over (r)}í Faustmann
IPC分类号: A61K31/505
CPC分类号: C07D401/04
摘要: Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described. The structure diagram below shows the chemical structure of imatinib mesylate.
摘要翻译: 描述了甲磺酸伊马替尼的溶剂合物和结晶形式。 此外,描述了制备这种溶剂化物的方法和甲磺酸伊马替尼的结晶形式。 下面的结构图显示了甲磺酸伊马替尼的化学结构。
-
26.
公开(公告)号:US20100256392A1
公开(公告)日:2010-10-07
申请号:US12743568
申请日:2008-11-21
申请人: Ales Gavenda , Ettore Bigatti , Alexandr Jegorov , Augusto Canavesi , Pavel Vraspir , Judith Aronhime , Peter Lindsay MacDonald , Francesca Scarpitta , Marco Villa , Paolo Angioletti
发明人: Ales Gavenda , Ettore Bigatti , Alexandr Jegorov , Augusto Canavesi , Pavel Vraspir , Judith Aronhime , Peter Lindsay MacDonald , Francesca Scarpitta , Marco Villa , Paolo Angioletti
IPC分类号: C07D403/06
CPC分类号: C07D403/06
摘要: The present invention provides polymorphs of Sunitinib base and processes for preparation thereof.
摘要翻译: 本发明提供舒尼替尼碱基的多晶型物及其制备方法。
-
公开(公告)号:US20100256158A1
公开(公告)日:2010-10-07
申请号:US12814916
申请日:2010-06-14
申请人: Ondrej SIMO , Jirí Filipcik , Alexandr Martaus , Alexandr Jegorov , Ales Gavenda , Judith Aronhime , Pavel Vraspír , Tamás Koltai , Jirí Faustmann , Roman Gabriel
发明人: Ondrej SIMO , Jirí Filipcik , Alexandr Martaus , Alexandr Jegorov , Ales Gavenda , Judith Aronhime , Pavel Vraspír , Tamás Koltai , Jirí Faustmann , Roman Gabriel
IPC分类号: A61K31/496 , C07D417/14 , A61P35/00
CPC分类号: C07D417/12
摘要: Provided is dasatinib, solvates thereof and their crystalline forms, methods for their preparation, and pharmaceutical compositions thereof.
摘要翻译: 提供达沙替尼,其溶剂合物及其结晶形式,其制备方法及其药物组合物。
-
公开(公告)号:US07678799B2
公开(公告)日:2010-03-16
申请号:US10860864
申请日:2004-06-03
申请人: Anna Balanov , Judith Aronhime , Boaz Gome , Tamas Koltai , Natalia Shenkar , Marioara Mendelovici , Ehud Amir
发明人: Anna Balanov , Judith Aronhime , Boaz Gome , Tamas Koltai , Natalia Shenkar , Marioara Mendelovici , Ehud Amir
IPC分类号: C07D417/14
CPC分类号: C07D417/12 , A61K31/496
摘要: Provided is crystalline ziprasidone HCl and processes for preparation thereof.
摘要翻译: 提供了结晶齐拉西酮HCl及其制备方法。
-
公开(公告)号:US07589211B2
公开(公告)日:2009-09-15
申请号:US11527348
申请日:2006-09-25
IPC分类号: A61K31/675 , C07F9/06
CPC分类号: C07F9/6506
摘要: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
-
公开(公告)号:US20090156813A1
公开(公告)日:2009-06-18
申请号:US12315867
申请日:2008-12-04
申请人: Judith Aronhime , Ben-Zion Dolitzky , Eran Luvchick , Jean Hildesheim , Hagit Eisen-Nevo , Reuven Izsak
发明人: Judith Aronhime , Ben-Zion Dolitzky , Eran Luvchick , Jean Hildesheim , Hagit Eisen-Nevo , Reuven Izsak
IPC分类号: C07D401/12
CPC分类号: C07D215/227 , A61K31/496
摘要: The invention encompasses aripiprazole crystalline forms, methods of preparing the same, and pharmaceutical compositions having aripiprazole crystalline forms.
摘要翻译: 本发明包括阿立哌唑晶形,其制备方法和具有阿立哌唑结晶形式的药物组合物。
-
-
-
-
-
-
-
-
-